Optimization of experimental human leukemia models (review)
- Authors: Pankov D.D.1, Rumyantsev A.G.2
-
Affiliations:
- Federal Research Center of Pediatric Hematology, Oncology and Immunology named after Dmitry Rogachev, Ministry of Health of Russia Memorial Sloan-Kettering Cancer Center
- Federal Research Center of Pediatric Hematology, Oncology and Immunology named after Dmitry Rogachev, Ministry of Health of Russia
- Issue: Vol 7, No 4 (2012)
- Pages: 48-52
- Section: BASIC RESEARCH
- Published: 23.11.2012
- URL: https://oncohematology.abvpress.ru/ongm/article/view/76
- DOI: https://doi.org/10.17650/1818-8346-2012-7-4-48-52
- ID: 76
Cite item
Full Text
Abstract
Actual problem of assessing immunotherapy prospects including antigenpecific cell therapy using animal models was covered in this review.
Describe the various groups of currently existing animal models and methods of their creating – from different immunodeficient mice to several
variants of tumor cells engraftment in them. The review addresses the possibility of tumor stem cells studying using mouse models for the leukemia treatment with adoptive cell therapy including WT1. Also issues of human leukemia cells migration and proliferation in a mice with
different immunodeficiency degree are discussed. To assess the potential immunotherapy efficacy comparison of immunodeficient mouse model with clinical situation in oncology patients after chemotherapy is proposed.
About the authors
D. D. Pankov
Federal Research Center of Pediatric Hematology, Oncology and Immunology named after Dmitry Rogachev, Ministry of Health of RussiaMemorial Sloan-Kettering Cancer Center
Author for correspondence.
Email: pankovd@mskcc.org
Russian Federation
A. G. Rumyantsev
Federal Research Center of Pediatric Hematology, Oncology and Immunology named after Dmitry Rogachev, Ministry of Health of RussiaRussian Federation
References
Supplementary files

